(MENAFN - Arab News) Local and international experts will gather in Riyadh on Saturday to discuss the latest advances in the battle against breast cancer at the San Antonio Breast Cancer Symposium. The symposium is to be held for the seventh consecutive year in the Saudi capital.
The two-day conference is sponsored by King Saud bin Abdulaziz University for Health Sciences and will be held in cooperation with the authorities of the San Antonio Breast Cancer Symposium.
Symposium Chairman Um-Ulkhair Abdullah Abu-Alkhair said the meeting will be held under the aegis of the chief executive officer of the National Guard Health Affairs and President of King Saud bin Abdulaziz University for Health Sciences Bandar bin Abdul Mohsen Al-Knawy.
Abu-Alkhair said the symposium which will be attended by local and international speakers and include specialized local and foreign oncologists. It will highlight the most important recent developments presented by the American Association for Cancer Research.
For the past 35 years, the San Antonio Breast Cancer Symposium's mission has been to provide state-of-the-art information on breast cancer research. From a one-day regional conference, the symposium has grown to a five-day program attended by a broad international audience of academic and private researchers and physicians from over 100 countries.
The symposium aims to achieve a balance of clinical, translational and basic research, providing a forum for interaction, communication and education for a broad spectrum of researchers, health professionals and those with a special interest in breast cancer.
In 2007, the Cancer Therapy & Research Center (CTRC) at UT Health Science Center San Antonio and the American Association for Cancer Research (AACR) announced a collaboration for the future of the San Antonio Breast Cancer Symposium. The symposium has been renamed the CTRC-AACR San Antonio Breast Cancer Symposium.
Complementing the clinical strengths of the highly regarded annual San Antonio Breast Cancer Symposium, the AACR's scientific prestige in basic, translational and clinical cancer research will create a unique and comprehensive scientific meeting that will advance breast cancer research for the benefit of patients.
In 2005, Baylor College of Medicine became a joint sponsor of the symposium and will remain in the CTRC-AACR collaboration.
The symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis and therapy of breast cancer and premalignant breast disease to an international audience of academic and private physicians and researchers.
The scientific program consists of plenary lectures and mini-symposia by experts in clinical and basic research; selected slide and poster presentations chosen from the submitted abstracts; educational sessions, award lectures, panel and case discussions and forums. General sessions are 2 to 3 hours in duration and are the vehicle for slide presentations, which are allotted 10 minutes each followed by five minutes of discussion. Poster sessions are two hours long.
